Skip to main content
. 2022 Nov 30;7:384. doi: 10.1038/s41392-022-01254-x

Fig. 8.

Fig. 8

FFAR4 suppressing cisplatin-induced senescence via activating SirT3 in AKI mice. a, b Relative mRNA and protein expression of SirT3 in TCMK-1 cells transfected with SirT3 siRNA (n = 3; ****P < 0.001, *P < 0.05, ns. no significant). c Protein expression of p53, p21, LaminB1, p-Rb/Rb, ɣH2A.X and IL-6 in TCMK-1 cells transfected with SirT3 siRNA detected by western blotting and quantified by densitometry (n = 3; ****P < 0.0001, **P < 0.01, CP + NC siRNA vs. NC siRNA; $$$$P < 0.0001, CP + TUG891 + NC siRNA vs. CP + NC siRNA; ####P < 0.0001, ###P < 0.001, CP + TUG891 + FFAR4 siRNA vs. CP + TUG891 + NC siRNA). d, e Relative mRNA and protein expression of SirT3 in TCMK-1 cells transfected with transfected with empty plasmid (pVector) or plasmid expressing SirT3 (pSirT3) (n = 3; ****P < 0.001, ns no significant). f Protein expression of p53, p21, LaminB1, p-Rb/Rb,ɣH2A.X and IL-6 in TCMK-1 cells transfected with empty plasmid (pVector) or plasmid expressing SirT3 (pSirT3) detected by western blotting and quantified by densitometry (n = 3; ****P < 0.0001, CP + NC siRNA+pVector vs. NC siRNA+ pVector; $$$$P < 0.0001, $$P < 0.01, CP + FFAR4 siRNA+pVector vs. CP + NC siRNA+pVector; ####P < 0.0001, CP + FFAR4 siRNA+pSirT3 vs. CP + FFAR4 siRNA+pVector). Data are presented as mean ± SD. CP cisplatin